trending Market Intelligence /marketintelligence/en/news-insights/trending/widy-8vskzfqw-d7ecmevg2 content esgSubNav
In This List

Novus Therapeutics raises $8.5M through stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Novus Therapeutics raises $8.5M through stock offering

Novus Therapeutics Inc. raised $8.5 million via the sale of 2,463,966 shares of the company.

Irvine, Calif.-based Novus Therapeutics is a pharmaceutical company focused on the development of ear, nose and throat products.

The company was previously known as Tokai Pharmaceuticals Inc.